We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
+10.72%
1 Year Est. Return
+80.99%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.85B
AUM Growth
+$338M
Cap. Flow
+$79.4M
Cap. Flow %
1.36%
Top 10 Hldgs %
45.51%
Holding
707
New
76
Increased
198
Reduced
354
Closed
64

Top Buys

Rank Stock Value
1
TER icon
Teradyne
TER
+$60.1M
2
TSLA icon
Tesla
TSLA
+$32.1M
3
TSEM icon
Tower Semiconductor
TSEM
+$29.6M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$29M
5
PDD icon
Pinduoduo
PDD
+$28.1M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$77.7M
2
BE icon
Bloom Energy
BE
+$53.1M
3
HOOD icon
Robinhood
HOOD
+$24.9M
4
SAP icon
SAP
SAP
+$24.1M
5
BIDU icon
Baidu
BIDU
+$21.5M

Sector Composition

Rank Sector Weight
1 Technology 51.21%
2 Communication Services 15.38%
3 Consumer Discretionary 13.01%
4 Healthcare 6.62%
5 Consumer Staples 4.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MGNX icon
676
MacroGenics
MGNX
$233M
-1,303
Closed -$2.19K
MRSN
677
DELISTED
Mersana Therapeutics
MRSN
-94
Closed -$729
MRUS
678
DELISTED
Merus
MRUS
-1,627
Closed -$153K
MXCT icon
679
MaxCyte
MXCT
$108M
-2,256
Closed -$3.56K
NEM icon
680
Newmont
NEM
$96.2B
-1,957
Closed -$165K
NI icon
681
NiSource
NI
$21.5B
-290
Closed -$12.6K
NKTX icon
682
Nkarta
NKTX
$152M
-1,463
Closed -$3.03K
NVO
683
Novo Nordisk
NVO
$228B
-120,000
Closed -$6.66M
OLP
684
One Liberty Properties
OLP
$542M
-280
Closed -$6.19K
ON icon
685
ON Semiconductor
ON
$30.7B
-83,227
Closed -$4.1M
PGRE
686
DELISTED
Paramount Group
PGRE
-2,968
Closed -$19.4K
PLRX icon
687
Pliant Therapeutics
PLRX
$65M
-1,264
Closed -$1.87K
RKT icon
688
Rocket Companies
RKT
$38.8B
-2,797
Closed -$54.2K
RNAC icon
689
Cartesian Therapeutics
RNAC
$218M
-549
Closed -$5.61K
SCPH
690
DELISTED
scPharmaceuticals
SCPH
-1,147
Closed -$6.5K
SITC icon
691
SITE Centers
SITC
$236M
-794
Closed -$7.15K
SNOW icon
692
Snowflake
SNOW
$98.1B
-247
Closed -$55.7K
STRO icon
693
Sutro Biopharma
STRO
$386M
-192
Closed -$1.67K
TCRX icon
694
TScan Therapeutics
TCRX
$48.5M
-1,020
Closed -$1.86K
TRML
695
DELISTED
Tourmaline Bio
TRML
-555
Closed -$26.5K
TTD icon
696
Trade Desk
TTD
$8.97B
-89,252
Closed -$4.37M
UHT
697
Universal Health Realty Income Trust
UHT
$621M
-218
Closed -$8.54K
VRNA
698
DELISTED
Verona Pharma
VRNA
-1,826
Closed -$195K
VTLE
699
DELISTED
Vital Energy
VTLE
-7,376
Closed -$125K
WB icon
700
Weibo
WB
$1.97B
-74,710
Closed -$926K

Similar funds

GF Fund Management's Q4 2025 Portfolio in Review

As of Q4 2025, GF Fund Management held 707 positions worth $5.85B, up 6.1% from $5.51B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

GF Fund Management's Q4 2025 filing shows 76 new, 198 increased, 354 reduced and 64 closed positions. Its largest new stake was Teradyne: 350,137 shares worth $67.8M. The largest sale was Broadcom, an estimated $77.7M.

By sector, the portfolio is most concentrated in Technology at 51% of assets, up from 49% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • GF Fund Management's largest Q4 2025 buy was Teradyne: 350,137 shares worth $67.8M.
  • GF Fund Management added most to Tesla in Q4 2025, an estimated $32.1M increase.
  • GF Fund Management's biggest Q4 2025 reduction was Broadcom, cutting an estimated $77.7M.
  • GF Fund Management fully exited Baidu in Q4 2025, selling an estimated $21.5M.
  • GF Fund Management's ten largest holdings make up 46% of its $5.85B portfolio in Q4 2025.
  • GF Fund Management opened 76 new positions and closed 64 in Q4 2025.
  • GF Fund Management's portfolio value rose 6.1% quarter-over-quarter to $5.85B.

Based on GF Fund Management's 13F filing for Q4 2025, filed 27 Jan 2026.